Ratlam

“The third party consultants are regularly visiting our manufacturing units which are under USFDA import alert/warning letter and are assisting us in implementing robust remediation measures in a proper and timely manner,” Ipca said in a clarification to stock exchanges.

Geneva-based fund not to order drug from Ipca, stock cracks 14%

Ipca received warning letter from USFDA for its Ratlam (Madhya Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa) manufacturing units.

Ipca Labs gets USFDA warning letter for 3 units, stock crashes

Ipca Labs already voluntarily suspended shipments of its APIs and formulations for the US market till USFDA inspection observations are resolved.

Positive on Lupin on strong pipeline for US mkt: IIFL

Pharma Analyst, Abhishek Sharma of IIFL spoke with Ekta Batra & Anuj Singhal of CNBC-TV18. He shared his reading and outlook on the pharmaceutical space.

IPCA Labs tanks 9%, gets USFDA import alert for Ratlam unit

Investors offloaded a huge chunk of shares of Ipca Laboratories on Friday. The stock fell nearly 9 percent intraday. The pharmaceutical firm received import alert from US Food and Drug Administration for its Ratlam unit due to violations of standard production practices.

Buy IPCA; it is well valued for long-term investors: Angel

Sarabjit Kaur Nangra of Angel Broking says the stock is very well valued at the current prices and adds that the company‘s cautiousness about maintaining its profitability is a positive.

Rail blockades held in MP over wheat MSP issue

Demanding a hike in the minimum support price of wheat from Rs 1,285 per quintal to Rs 1,800, Kisan Morcha of Madhya Pradesh BJP today staged a rail blockade at various places in the state.